查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1806649

按產品類型、技術、最終用戶和應用分類的單細胞定序市場—2025-2030 年全球預測

Single Cell Sequencing Market by Product Type, Technology, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計單細胞定序市場規模在 2024 年將達到 24.9 億美元，2025 年將達到 28.3 億美元，到 2030 年將達到 54.5 億美元，複合年成長率為 13.94%。

主要市場統計數據
基準年2024年 24.9億美元
預計2025年 28.3億美元
預測年份 2030 54.5億美元
複合年成長率（%） 13.94%

揭示單細胞定序在現代研究中的變革力量及其在精準醫療和生物技術突破中的關鍵作用

在精準醫療和創新生物技術的時代，單細胞定序已成為一種突破性的工具，能夠以前所未有的解析度揭示細胞異質性。這項技術使研究人員能夠在單一細胞層面揭示組織的複雜性，為癌症生物學、免疫學、發育生物學等領域的突破鋪平了道路。

隨著新的液滴和微孔技術重新定義研究邊界和臨床應用，繪製單細胞定序的演變過程

過去十年，隨著微流體液滴系統、微孔平台和高通量板式解決方案的興起，單細胞定序經歷了變革性的變化。液滴式方法透過將單一細胞封裝在納升液滴中，實現了單次運行中數萬個細胞的平行處理，從而實現了細胞的普及。微孔系統能夠在高密度陣列中實現精確的細胞捕獲和條碼編碼，在通量和可靠的資料品質之間取得平衡。同時，板式技術持續致力於解決需要對少量細胞進行深度定序的特殊應用。

評估2025年後即將實施​​的美國關稅對單細胞定序進口和供應鏈的累積影響

美國擬議的關稅將於2025年生效，這將透過提高關鍵設備、耗材和試劑的進口課稅，對單細胞定序生態系統產生影響。製造商和最終用戶可能會面臨定序儀和微流體設備的更高到岸成本，這可能會促使供應鏈重組，並加速國內製造業的舉措。

關鍵細分洞察，用於指南單細胞定序產品類型、技術、最終用戶和應用方面的策略決策

細緻入微地了解市場區隔對於使產品開發和上市策略與最終用戶需求保持一致至關重要。根據產品類型，單細胞定序系統包括儀器和試劑/套件。儀器包括用於分離稀有亞群的專用細胞分選儀、支援微流體封裝工作流程的微流體設備，以及針對單細胞讀取深度最佳化的次世代定序儀。試劑和套件包括可維持轉錄本完整性的客製化擴增化學試劑、用於對多重樣本進行索引的標記試劑套件，以及旨在最大程度地從單一細胞中回收核酸的裂解試劑套件。

解讀影響美洲、中東和非洲以及亞太地區單細胞定序市場的區域動態和成長動力

區域動態將顯著影響單細胞定序的普及和發展。在美洲，北美強大的學術生態系統正在推動尖端平台的早期應用，而主要的生物製藥叢集正在加速向臨床應用的轉型。對國內製造和合作研究計畫的投資將增強該地區創新和商業化新工作流程的能力。

確定推動單細胞定序技術創新與合作的領先公司的策略和競爭定位

產業領導者正在策略性地定位自身，以滿足對單細胞定序平台和耗材日益成長的需求。 10x Genomics 和 Illumina 等儀器製造商不斷改進其硬體設計，將微流體創新與先進的光學和流體處理技術相結合，以提高數據吞吐量和可靠性。作為這些努力的補充，包括 BD Biosciences 和 Fluidigm 在內的專業供應商提供承包解決方案，簡化細胞捕獲和條碼編碼流程，從而降低最終用戶的工作流程複雜性。

為行業領導者提供可行的策略，以最佳化單細胞測序投資、優先考慮夥伴關係關係並應對不斷變化的法規環境

產業領導者必須採取積極主動的方式，充分利用不斷擴展的單細胞定序市場。投資應優先考慮聯合開發夥伴關係，將儀器功能與尖端試劑化學技術結合，並確保在不同樣本類型之間實現無縫的工作流程和驗證。與領先的學術機構和製藥公司建立聯合技術藍圖，將有助於促進早期應用和聯合品牌機會，從而提高市場滲透率。

嚴謹的調查方法的細節，結合了專家定性訪談、定量資料分析和全面的二次研究途徑

我們的調查方法融合了定性和定量分析，旨在對單細胞測序領​​域進行全面而穩健的分析。主要研究包括對關鍵意見領袖（包括學術研究人員、臨床實驗室主任和製藥研發高管）進行深入訪談，以收集關於技術採用障礙、工作流程偏好和新興應用需求的第一手見解。

總結影響單細胞定序在前沿研究應用中發展軌蹟的關鍵見解的未來前景和戰略意義

摘要：單細胞定序處於科學創新的前沿，打破了傳統的細胞解析度障礙，並促進了腫瘤學、免疫學、神經病學等領域的突破。隨著新型液滴和微孔平台的普及以及整合化學技術簡化工作流程，該技術有望再形成基礎研究和臨床診斷。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 整合多體學單細胞分析平台可實現全面的細胞分析和疾病路徑洞察
  • 微流體高通量單細胞定序平台的進步降低了大規模研究的單細胞成本
  • 利用空間分辨轉錄組學和單細胞定序來保存組織結構和細胞相互作用
  • 擴大使用人工智慧和機器學習來對複雜的單細胞測序資料集進行可擴展的解釋
  • 單細胞免疫組庫定序的出現，用於繪製克隆多樣性和表現型標記表達圖譜
  • 開發可攜式奈米孔定序序裝置，最佳化臨床現場單細胞轉錄組分析
  • 開發使用 DNA 條碼的樣本連接複用策略，以提高大規模單細胞實驗的通量並減少批次效應
  • 有針對性的單細胞表觀基因檢測的出現，可以同時進行染色質可及性和組蛋白修飾分析
  • 整合活細胞成像和單細胞RNA定序，將時間表現型變化與轉錄組動態關聯起來
  • 開發結合單細胞分離和文庫製備的自動化平台，以簡化臨床診斷工作流程

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 單細胞定序市場（依產品類型）

  • 裝置
    • 細胞分選裝置
    • 微流體設備
    • 序列器
  • 試劑和套件
    • 擴增試劑套件
    • 標籤套件
    • 裂解試劑套件

9. 單細胞定序市場（依技術）

  • 基於液滴
  • 微孔板
  • 板基

10. 單細胞定序市場（依最終用戶）

  • 學術研究
    • 研究機構
    • 大學
  • 臨床診斷
    • 診斷實驗室
    • 醫院
  • 臨床研究組織
    • 臨床服務
    • 臨床前服務
  • 製藥和生物技術
    • 生物標記開發
    • 藥物研發

11. 單細胞定序市場（依應用）

  • 癌症研究
    • 循環性腫瘤細胞
    • 腫瘤異質性
  • 發育生物學
  • 免疫學
    • 免疫組庫分析
    • T細胞分析
  • 神經病學
    • 神經退化性疾病
    • 神經元分析

12. 美國單細胞定序市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 歐洲、中東和非洲單細胞定序市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

14. 亞太地區單細胞定序市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • 10x Genomics, Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • Becton, Dickinson and Company
    • Standard BioTools Inc.
    • Takara Bio Inc.
    • Miltenyi Biotec GmbH
    • Agilent Technologies, Inc.
    • Arima Genomics LLC
    • BGI Group
    • CD Genomics
    • Cell Signaling Technology, Inc.
    • HiFiBiO Therapeutics, Inc.
    • iRepertoire, Inc.
    • Merck KGaA
    • Oxford Nanopore Technologies plc.
    • Pacific Biosciences of California, Inc.
    • Parse Biosciences Inc.
    • QIAGEN GmbH
    • Revvity, Inc.

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-035B5C3A4E3B

The Single Cell Sequencing Market was valued at USD 2.49 billion in 2024 and is projected to grow to USD 2.83 billion in 2025, with a CAGR of 13.94%, reaching USD 5.45 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 2.49 billion
Estimated Year [2025] USD 2.83 billion
Forecast Year [2030] USD 5.45 billion
CAGR (%) 13.94%

Unveiling the transformative power of single cell sequencing in modern research and its critical role in shaping precision medicine and biotechnology breakthroughs

In the era of precision medicine and transformative biotechnology, single cell sequencing has emerged as a revolutionary tool that dissects cellular heterogeneity with unprecedented resolution. This technology enables researchers to unravel the complexity of tissues at the individual cell level, paving the way for breakthroughs in cancer biology, immunology, developmental biology, and beyond.

By capturing transcriptomic and genomic information from individual cells, scientists can identify rare cell populations, map differentiation trajectories, and characterize tumor microenvironments with a depth that bulk sequencing cannot achieve. As a result, single cell sequencing is redefining how we understand disease mechanisms, accelerating biomarker discovery, and informing the development of targeted therapies. With continuous innovations in instrumentation, chemistry, and computational analysis, the field is on the cusp of even greater sophistication and accessibility.

As research institutions, pharmaceutical companies, and clinical laboratories adopt these advanced workflows, the strategic importance of single cell sequencing grows. Decision-makers must understand the technological foundations and transformative potential of this field to harness its capabilities effectively. This introduction sets the stage for an in-depth exploration of the shifts, challenges, and opportunities that will shape the trajectory of single cell sequencing in the coming years.

Charting the evolution of single cell sequencing as emerging droplet and microwell technologies redefine research boundaries and clinical applications

Over the past decade, single cell sequencing has undergone transformative shifts driven by the rise of microfluidic droplet systems, microwell platforms, and high-throughput plate-based solutions. Droplet-based methods have democratized access by encapsulating individual cells in nanoliter droplets, enabling parallel processing of tens of thousands of cells in a single run. Microwell-based systems offer precise cell capture and barcoding in dense arrays, balancing throughput with robust data quality. Meanwhile, plate-based techniques continue to serve specialized applications requiring deep sequencing of fewer cells.

These technological leaps have been accompanied by advancements in library preparation chemistries, molecular barcoding strategies, and bioinformatic pipelines. As researchers demand greater sensitivity and lower input requirements, instrument vendors and reagent developers have responded with streamlined workflows and integrated analysis software. The convergence of hardware miniaturization and cloud-native data processing is further reducing barriers to entry, empowering academic laboratories and biotech startups alike.

Looking ahead, the landscape will be defined by continued integration of multi-omic approaches, spatial context preservation, and real-time data visualization. These emerging paradigms promise to expand the application scope of single cell sequencing, from early disease detection and immunoprofiling to monitoring therapeutic efficacy in clinical trials. Such shifts underscore the importance of staying abreast of platform innovations and aligning research strategies with evolving capabilities.

Assessing the cumulative impact of impending US tariffs on single cell sequencing imports and supply chains through 2025 and beyond

The proposed United States tariffs effective in 2025 are poised to influence the single cell sequencing ecosystem by increasing import levies on critical instruments, consumables, and reagents. Manufacturers and end users may face higher landed costs for sequencers and microfluidic devices, potentially prompting supply chain realignments and accelerated domestic manufacturing initiatives.

In response, many global instrument vendors are exploring localized assembly hubs to mitigate tariff impact while preserving price competitiveness. Parallel efforts by reagent suppliers to establish regional production facilities aim to ensure uninterrupted supply of barcoding chemistries, amplification kits, and labeling reagents. However, scaling local manufacturing involves rigorous validation processes and adherence to quality standards, which could introduce short-term bottlenecks.

As laboratories adjust procurement strategies, some may seek alternative suppliers or re-evaluate long-term service contracts, emphasizing total cost of ownership rather than unit price. Collaboration between instrument OEMs and reagent innovators will become even more critical to deliver integrated solutions that justify premium pricing through enhanced performance and support. Moreover, stakeholders should monitor policy developments closely, using scenario planning to anticipate further trade policy shifts.

Ultimately, the cumulative impact of these tariffs will hinge on the ability of the industry to adapt supply chain models, optimize inventory buffers, and leverage strategic partnerships to sustain momentum in high-impact research programs.

Illuminating key segmentation insights to guide strategic decisions across product types technologies end users and applications in single cell sequencing

A nuanced understanding of market segmentation is essential for aligning product development and go-to-market strategies with end-user needs. Based on product type, the single cell sequencing ecosystem encompasses both instruments and reagents and kits. Instruments span specialized cell sorters that isolate rare subpopulations, microfluidic devices that enable high-throughput encapsulation workflows, and next-generation sequencers optimized for single cell read depth. Reagents and kits comprise tailored amplification chemistries that preserve transcript integrity, labeling kits for multiplexed sample indexing, and lysis kits engineered to maximize nucleic acid recovery from individual cells.

In parallel, technological segmentation distinguishes droplet-based approaches, which excel in scalability; microwell-based platforms, which balance throughput and data fidelity; and plate-based solutions, which facilitate deep profiling of targeted cell cohorts. Each technology addresses unique research questions, from broad discovery studies to focused lineage tracing investigations.

End users range from academic research institutions-spanning both universities and independent research institutes-to clinical diagnostics laboratories and hospital centers where patient-derived samples inform precision oncology decisions. Clinical research organizations, subdivided into preclinical and clinical service providers, increasingly integrate single cell workflows into drug development pipelines. Similarly, pharmaceutical and biotech companies leverage these tools for biomarker discovery and drug screening, driving collaborations with instrument and reagent partners.

Applications further segment into cancer research, including studies of circulating tumor cells and tumor heterogeneity, developmental biology investigations, immunology analyses such as immune repertoire profiling and T cell functional assays, and neurological research focused on neurodegenerative disease models and neuronal cell type mapping. This layered segmentation framework empowers stakeholders to tailor solutions to the precise demands of diverse research and clinical markets.

Deciphering regional dynamics and growth drivers shaping the single cell sequencing market across Americas Europe Middle East Africa and Asia Pacific

Regional dynamics profoundly shape the adoption and evolution of single cell sequencing. In the Americas, robust academic ecosystems in North America drive early adoption of cutting-edge platforms, while leading biopharmaceutical clusters accelerate translation into clinical applications. Investment in domestic manufacturing and collaborative research initiatives bolsters the region's capacity to innovate and commercialize new workflows.

In Europe, Middle East, and Africa, cross-border consortia support large-scale population studies and translational research, leveraging harmonized regulatory frameworks and funding partnerships. European Union-led initiatives promote data sharing and standardization, facilitating multi-center studies in oncology, immunology, and neurobiology. Emerging markets in the Middle East and Africa are investing in infrastructure and training to integrate single cell techniques into regional health priorities.

Asia-Pacific exhibits the fastest growth trajectory, driven by strategic government funding programs, expanding biotechnology hubs, and a growing network of contract research organizations. Countries across the region are establishing centers of excellence focused on single cell genomics to support drug discovery and precision diagnostics. Local partnerships between instrument providers and regional distributors enhance accessibility and technical support, ensuring that researchers can fully leverage advanced sequencing platforms.

These distinct regional landscapes underscore the importance of tailored market entry and expansion strategies, from localized manufacturing and regulatory alignment to targeted collaborator networks.

Uncovering the strategies and competitive positioning of leading corporations driving innovation and collaboration in single cell sequencing technologies

Leading industry players have strategically positioned themselves to capitalize on the growing demand for single cell sequencing platforms and consumables. Instrument manufacturers such as 10x Genomics and Illumina continue to refine hardware designs, integrating microfluidic innovations with advanced optics and fluid handling to enhance data throughput and reliability. Complementing these efforts, specialized providers-including BD Biosciences and Fluidigm-offer turnkey solutions that streamline cell capture and barcoding, reducing workflow complexity for end users.

On the reagents front, companies like Takara Bio and Bio-Rad Laboratories have invested heavily in optimizing chemistries for single cell library preparation, focusing on sensitivity, specificity, and compatibility with diverse sample types. Meanwhile, emerging biotech firms are forging strategic alliances with large pharmaceutical organizations, co-developing custom assays tailored to high-value therapeutic areas such as immuno-oncology and regenerative medicine.

Collaborative partnerships between instrument OEMs, reagent suppliers, and software innovators are increasingly common, as integrated platforms become essential to address the data analysis bottleneck inherent to single cell studies. By uniting expertise in molecular biology, engineering, and bioinformatics, these consortia accelerate time-to-insight for researchers and bolster competitive moats through proprietary workflows and support services.

The success of these companies hinges on their ability to anticipate evolving user requirements, drive continuous innovation, and foster robust, user-centered ecosystems that extend beyond hardware and reagents into informatics and application support.

Empowering industry leaders with actionable strategies to optimize investment prioritize partnerships and navigate evolving regulatory environments in single cell sequencing

Industry leaders must adopt a proactive approach to capitalize on the expanding single cell sequencing landscape. Investments should prioritize co-development partnerships that align instrument capabilities with cutting-edge reagent chemistries, ensuring seamless workflows and validation across diverse sample types. Establishing joint technology roadmaps with key academic and pharmaceutical collaborators will foster early adoption and co-branding opportunities that enhance market penetration.

Building resilient supply chains is equally critical; diversifying manufacturing footprints and qualifying secondary suppliers will mitigate risks associated with geopolitical shifts, including tariff changes and trade restrictions. Leaders should implement agile inventory management systems to balance just-in-time delivery with strategic buffer stock, avoiding disruptions to high-priority research programs.

Embedding data analysis solutions within instrument offerings can create differentiated value propositions. By integrating cloud-native bioinformatics platforms and developing intuitive visualization tools, companies can lower the barrier to entry for laboratories lacking deep computational expertise. Tailored training programs, combined with certification pathways for single cell workflows, will reinforce customer loyalty and drive recurring revenue streams through reagent and service contracts.

Lastly, engaging with regulatory bodies and standardization consortia will position organizations to influence emerging guidelines for clinical translation of single cell assays. By contributing to best practice frameworks, leaders can accelerate approval pathways for diagnostic applications and solidify their role in the future of precision medicine.

Detailing a rigorous research methodology blending qualitative expert interviews quantitative data analysis and comprehensive secondary research approaches

Our research methodology integrates both qualitative and quantitative approaches to ensure a robust and comprehensive analysis of the single cell sequencing landscape. Primary research entailed in-depth interviews with key opinion leaders, including academic investigators, clinical laboratory directors, and pharmaceutical R&D executives, to gather firsthand insights on technology adoption barriers, workflow preferences, and emerging application needs.

On the quantitative side, publicly available data from peer-reviewed publications, conference proceedings, and patent filings were systematically analyzed to track technology maturation, funding trends, and geographic diffusion. We also mined instrument and reagent performance metrics to compare sensitivity, throughput, and cost-efficiency across competing platforms.

Secondary research leveraged industry white papers, regulatory filings, and corporate disclosures to validate primary findings and refine market segmentation. Cross-validation techniques were applied to reconcile disparate data sources, ensuring consistency and accuracy. Our analytical framework combined trend analysis, scenario modeling, and SWOT assessments to identify strategic imperatives and forecast potential market shifts.

This blended methodology, underpinned by continuous data quality checks and expert review panels, delivers actionable intelligence to support investment decisions, product development roadmaps, and go-to-market strategies in the fast-evolving single cell sequencing space.

Summarizing critical insights future outlook and strategic implications shaping the trajectory of single cell sequencing in cutting edge research applications

In summary, single cell sequencing stands at the forefront of scientific innovation, dismantling traditional barriers to cellular resolution and fueling breakthroughs across oncology, immunology, neurology, and beyond. As emerging droplet and microwell platforms democratize access, and integrated chemistries streamline workflows, the technology is poised to reshape both basic research and clinical diagnostics.

Navigating the evolving landscape requires a deep understanding of segmentation dynamics-from product typologies and technological modalities to end-user applications and geographic nuances. Concurrently, the industry must adapt to external pressures, including upcoming trade policies and shifting regulatory expectations. Leading organizations are already forging collaborative partnerships, investing in domestic supply chains, and embedding analytics solutions to maintain competitive advantage.

The strategic imperatives distilled here underscore the importance of aligning innovation with user needs, diversifying risk exposures, and proactively engaging in standards development. By synthesizing these insights, decision-makers can chart a path toward sustainable growth, operational resilience, and scientific leadership in an era where single cell technologies redefine what is possible in life science research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of multi-omics single cell analysis platforms to enable holistic cellular profiling and disease pathway insights
  • 5.2. Advances in microfluidic high-throughput single cell sequencing platforms driving reductions in cost per cell for large studies
  • 5.3. Adoption of spatially resolved transcriptomics in single cell sequencing to preserve tissue architecture and cell interactions
  • 5.4. Increased use of artificial intelligence and machine learning for scalable interpretation of complex single cell sequencing datasets
  • 5.5. Emergence of single cell immune repertoire sequencing to map clonal diversity alongside phenotypic marker expression
  • 5.6. Development of portable nanopore sequencing devices optimized for on site single cell transcriptomic analysis in clinics
  • 5.7. Growth of sample multiplexing strategies using DNA barcoding to increase throughput and reduce batch effects in large scale single cell experiments
  • 5.8. Emergence of targeted single cell epigenomics assays enabling simultaneous chromatin accessibility and histone modification profiling
  • 5.9. Integration of live cell imaging with single cell RNA sequencing to correlate temporal phenotypic changes with transcriptomic dynamics
  • 5.10. Development of automation platforms combining single cell isolation and library preparation for streamlined clinical diagnostics workflows

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Single Cell Sequencing Market, by Product Type

  • 8.1. Introduction
  • 8.2. Instruments
    • 8.2.1. Cell Sorters
    • 8.2.2. Microfluidic Devices
    • 8.2.3. Sequencers
  • 8.3. Reagents And Kits
    • 8.3.1. Amplification Kits
    • 8.3.2. Labeling Kits
    • 8.3.3. Lysis Kits

9. Single Cell Sequencing Market, by Technology

  • 9.1. Introduction
  • 9.2. Droplet Based
  • 9.3. Microwell Based
  • 9.4. Plate Based

10. Single Cell Sequencing Market, by End User

  • 10.1. Introduction
  • 10.2. Academic Research
    • 10.2.1. Research Institutes
    • 10.2.2. Universities
  • 10.3. Clinical Diagnostics
    • 10.3.1. Diagnostic Labs
    • 10.3.2. Hospitals
  • 10.4. Clinical Research Organization
    • 10.4.1. Clinical Services
    • 10.4.2. Preclinical Services
  • 10.5. Pharma & Biotech
    • 10.5.1. Biomarker Development
    • 10.5.2. Drug Discovery

11. Single Cell Sequencing Market, by Application

  • 11.1. Introduction
  • 11.2. Cancer Research
    • 11.2.1. Circulating Tumor Cells
    • 11.2.2. Tumor Heterogeneity
  • 11.3. Developmental Biology
  • 11.4. Immunology
    • 11.4.1. Immune Repertoire Analysis
    • 11.4.2. T Cell Profiling
  • 11.5. Neurology
    • 11.5.1. Neurodegenerative Disease
    • 11.5.2. Neuronal Profiling

12. Americas Single Cell Sequencing Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Single Cell Sequencing Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Single Cell Sequencing Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific, Inc.
    • 15.3.3. 10x Genomics, Inc.
    • 15.3.4. F. Hoffmann-La Roche Ltd
    • 15.3.5. Bio-Rad Laboratories, Inc.
    • 15.3.6. Becton, Dickinson and Company
    • 15.3.7. Standard BioTools Inc.
    • 15.3.8. Takara Bio Inc.
    • 15.3.9. Miltenyi Biotec GmbH
    • 15.3.10. Agilent Technologies, Inc.
    • 15.3.11. Arima Genomics LLC
    • 15.3.12. BGI Group
    • 15.3.13. CD Genomics
    • 15.3.14. Cell Signaling Technology, Inc.
    • 15.3.15. HiFiBiO Therapeutics, Inc.
    • 15.3.16. iRepertoire, Inc.
    • 15.3.17. Merck KGaA
    • 15.3.18. Oxford Nanopore Technologies plc.
    • 15.3.19. Pacific Biosciences of California, Inc.
    • 15.3.20. Parse Biosciences Inc.
    • 15.3.21. QIAGEN GmbH
    • 15.3.22. Revvity, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. SINGLE CELL SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. SINGLE CELL SEQUENCING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. SINGLE CELL SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. SINGLE CELL SEQUENCING MARKET: RESEARCHAI
  • FIGURE 24. SINGLE CELL SEQUENCING MARKET: RESEARCHSTATISTICS
  • FIGURE 25. SINGLE CELL SEQUENCING MARKET: RESEARCHCONTACTS
  • FIGURE 26. SINGLE CELL SEQUENCING MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. SINGLE CELL SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CELL SORTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LABELING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LABELING KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LYSIS KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY LYSIS KITS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DROPLET BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DROPLET BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROWELL BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY MICROWELL BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PLATE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PLATE BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TUMOR HETEROGENEITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY TUMOR HETEROGENEITY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE REPERTOIRE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNE REPERTOIRE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY T CELL PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY T CELL PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURODEGENERATIVE DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONAL PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEURONAL PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 107. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 108. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 109. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 111. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 113. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 115. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 117. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 129. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 132. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 133. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 134. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 135. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 140. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 141. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 142. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES SINGLE CELL SEQUENCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 157. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 160. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 161. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 162. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 163. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 165. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 167. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 168. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 169. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 172. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 173. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 174. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 175. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 178. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 179. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 180. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 181. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. CANADA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 183. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 186. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 187. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 188. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 189. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 193. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 194. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 195. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 197. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 199. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 201. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 204. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 205. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 206. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 207. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. MEXICO SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 212. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 213. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 214. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 215. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 217. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 219. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 220. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 221. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 222. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 223. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 224. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 225. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 226. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 227. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 229. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 230. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 231. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 233. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. BRAZIL SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 235. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 238. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 239. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 240. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 241. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 243. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 246. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 247. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 248. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 249. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 250. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 251. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 252. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 253. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 256. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 257. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 259. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ARGENTINA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA SINGLE CELL SEQUENCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2025-2030 (USD MILLION)
  • TABLE 295. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 297. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY ACADEMIC RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 301. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 303. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATION, 2025-2030 (USD MILLION)
  • TABLE 305. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY PHARMA & BIOTECH, 2025-2030 (USD MILLION)
  • TABLE 307. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 309. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY CANCER RESEARCH, 2025-2030 (USD MILLION)
  • TABLE 311. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY IMMUNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED KINGDOM SINGLE CELL SEQUENCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 315. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 317. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
  • TABLE 319. GERMANY SINGLE CELL SEQUENCING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)

TABLE